Clinical effectivity of Donalgin--niflumic acid--in locomotor diseases.
D000632:Aminopyrine / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D009069:Movement Disorders / Q000188:drug therapy*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009544:Niflumic Acid / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D010653:Phenylbutazone / Q000627:therapeutic use
D004338:Drug Combinations; D009539:Nicotinic Acids; D000632:Aminopyrine; D009544:Niflumic Acid; C003769:phenylbutazone, propyphenazone drug combination; D010653:Phenylbutazone